血脂异常基层健康管理规范

2021-02-28 心脑血管病防治.2021.21(2):105-112

血脂异常是临床常见的慢性病,是动脉粥样硬化性心血管病(arteriosclerotic cardiovascular disease, ASCVD)的独立危险因素之一。基层血脂异常健康管理能有效控制心

中文标题:

血脂异常基层健康管理规范

发布机构:

发布日期:

2021-02-28

简要介绍:

血脂异常是临床常见的慢性病,是动脉粥样硬化性心血管病(arteriosclerotic cardiovascular disease, ASCVD)的独立危险因素之一。基层血脂异常健康管理能有效控制心血管病危险因素,对降低心血管病发病率、死亡率和致残率具有重要意义。但是,目前血脂异常的知晓率、治疗率和控制率仍处于较低水平,成人血脂异常防治指南实施相对复杂,在基层转化应用困难,本规范综合基层高血压管理实践经验,参照《中国成人血脂异常防治指南(2016 年修订版)》,在《浙江省血脂异常社区综合防治规范》试点实施基础上,经优化整合,形成基层血脂异常健康管理规范,用于个体血脂异常健康管理服务。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=血脂异常基层健康管理规范_俞蔚.pdf)] GetToolGuiderByIdResponse(projectId=1, id=aed661c0021050ea, title=血脂异常基层健康管理规范, enTitle=, guiderFrom=心脑血管病防治.2021.21(2):105-112, authorId=0, author=, summary=血脂异常是临床常见的慢性病,是动脉粥样硬化性心血管病(arteriosclerotic cardiovascular disease, ASCVD)的独立危险因素之一。基层血脂异常健康管理能有效控制心, cover=https://img.medsci.cn/2021522/1621698565612_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Feb 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>血脂异常是临床常见的慢性病,是动脉粥样硬化性心血管病(arteriosclerotic cardiovascular disease, ASCVD)的独立危险因素之一。基层血脂异常健康管理能有效控制心血管病危险因素,对降低心血管病发病率、死亡率和致残率具有重要意义。但是,目前血脂异常的知晓率、治疗率和控制率仍处于较低水平,成人血脂异常防治指南实施相对复杂,在基层转化应用困难,本规范综合基层高血压管理实践经验,参照《中国成人血脂异常防治指南(2016 年修订版)》,在《浙江省血脂异常社区综合防治规范》试点实施基础上,经优化整合,形成基层血脂异常健康管理规范,用于个体血脂异常健康管理服务。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=3785, tagName=血脂异常)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3785, guiderKeyword=血脂异常, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3618, appHits=717, showAppHits=0, pcHits=842, showPcHits=2897, likes=4, shares=72, comments=40, approvalStatus=1, publishedTime=Sat May 22 23:50:30 CST 2021, publishedTimeString=2021-02-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 22 23:49:31 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 23:15:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=血脂异常基层健康管理规范_俞蔚.pdf)])
血脂异常基层健康管理规范_俞蔚.pdf
下载请点击:
评论区 (32)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1202829, encodeId=56d61202829d7, content=对工作有很大的帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:49 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069490, encodeId=420e10694901d, content=受益良多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c65379867, createdName=ms2000000683409229, createdTime=Fri Nov 12 09:16:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064047, encodeId=454e106404edb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c385464155, createdName=ms3000002100246179, createdTime=Tue Oct 26 12:42:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061818, encodeId=88001061818c5, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Tue Oct 19 13:41:13 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053338, encodeId=32c6105333811, content=学习了很多的吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Mon Sep 20 20:30:51 CST 2021, time=2021-09-20, status=1, ipAttribution=)]
    2022-03-15 董彦钦

    对工作有很大的帮助

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1202829, encodeId=56d61202829d7, content=对工作有很大的帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:49 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069490, encodeId=420e10694901d, content=受益良多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c65379867, createdName=ms2000000683409229, createdTime=Fri Nov 12 09:16:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064047, encodeId=454e106404edb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c385464155, createdName=ms3000002100246179, createdTime=Tue Oct 26 12:42:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061818, encodeId=88001061818c5, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Tue Oct 19 13:41:13 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053338, encodeId=32c6105333811, content=学习了很多的吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Mon Sep 20 20:30:51 CST 2021, time=2021-09-20, status=1, ipAttribution=)]
    2021-11-12 ms2000000683409229

    受益良多

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1202829, encodeId=56d61202829d7, content=对工作有很大的帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:49 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069490, encodeId=420e10694901d, content=受益良多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c65379867, createdName=ms2000000683409229, createdTime=Fri Nov 12 09:16:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064047, encodeId=454e106404edb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c385464155, createdName=ms3000002100246179, createdTime=Tue Oct 26 12:42:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061818, encodeId=88001061818c5, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Tue Oct 19 13:41:13 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053338, encodeId=32c6105333811, content=学习了很多的吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Mon Sep 20 20:30:51 CST 2021, time=2021-09-20, status=1, ipAttribution=)]
    2021-10-26 ms3000002100246179

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1202829, encodeId=56d61202829d7, content=对工作有很大的帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:49 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069490, encodeId=420e10694901d, content=受益良多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c65379867, createdName=ms2000000683409229, createdTime=Fri Nov 12 09:16:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064047, encodeId=454e106404edb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c385464155, createdName=ms3000002100246179, createdTime=Tue Oct 26 12:42:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061818, encodeId=88001061818c5, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Tue Oct 19 13:41:13 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053338, encodeId=32c6105333811, content=学习了很多的吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Mon Sep 20 20:30:51 CST 2021, time=2021-09-20, status=1, ipAttribution=)]
    2021-10-19 hannah1001
  5. [GetPortalCommentsPageByObjectIdResponse(id=1202829, encodeId=56d61202829d7, content=对工作有很大的帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:49 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069490, encodeId=420e10694901d, content=受益良多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c65379867, createdName=ms2000000683409229, createdTime=Fri Nov 12 09:16:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064047, encodeId=454e106404edb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c385464155, createdName=ms3000002100246179, createdTime=Tue Oct 26 12:42:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061818, encodeId=88001061818c5, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Tue Oct 19 13:41:13 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053338, encodeId=32c6105333811, content=学习了很多的吧, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7995605070, createdName=鸿毳沉舟, createdTime=Mon Sep 20 20:30:51 CST 2021, time=2021-09-20, status=1, ipAttribution=)]
    2021-09-20 鸿毳沉舟

    学习了很多的吧

    0

拓展阅读

2010血脂异常老年人使用他汀类药物中国专家共识

中国心血管相关专家小组(统称) · 2010-01-01

2010 中国血脂异常老年人他汀类药物使用专家共识

中国老年学学会心脑血管病专业委员会 · 2010-07-01

2011ESC/EAS血脂异常指南

欧洲心脏病学会(ESC,European Society of Cardiology) · 2011-06-28

【期刊版】甘油三酯增高的血脂异常防治中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2011-09-10

2011年甘油三酯增高的血脂异常防治中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2011-09-10

2012AACE 美国内分泌医师学会血脂异常管理与动脉粥样硬化预防指南

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2012-03-15